AEGIRBIO AB Aktie - Unternehmensdaten & Kurse - SE0014401121 | MoneyPeak

AEGIRBIO AB

Share · SE0014401121 · A2P7ZC (XSTO)

No Price

n/a

Share Float & Liquidity

Free Float -

Shares Float -

Shares Outstanding 36,05 M

Company Profile for AEGIRBIO AB Share

AegirBio AB (publ), a diagnostic company, develops and commercializes tests to follow the dosage of biological drugs. The company focuses on therapeutic drug monitoring of biologic therapies in the multiple sclerosis, cancer, and autoimmune diseases. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. The company was incorporated in 2019 and is based in Lund, Sweden.

Get up to date insights from finAgent about AEGIRBIO AB

Company Data

Name AEGIRBIO AB

Company AegirBio AB (publ)

Website https://aegirbio.com

Primary Exchange

NASDAQ STOCKHOLM AB

WKN A2P7ZC

ISIN SE0014401121

Asset Class Share

Sector Healthcare

Industry Medical - Instruments & Supplies

CEO Marco Wititteveen

Market Capitalization 15 Mio

Country Sweden

Currency SEK

Employees 0,0 T

Address Ideongatan 3A, 223 70 Lund

IPO Date 2020-06-26

Ticker Symbols

Name	Symbol
NASDAQ STOCKHOLM AB	AEGIR.ST
Frankfurt	52Q.F

More Shares

Investors who hold AEGIRBIO AB also have the following shares in their portfolio:

HYBRID CAP.FUND.I 05/UND. Bond

MAXIMUS INC Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog

Im App Store herunterladen

Bei Google Play herunterladen

All rights reserved © LCP GmbH 2025